UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis

Journal of the American Society of Nephrology, 2015-08, Vol.26 (8), p.1855-1876

2015

Volltextzugriff (PDF)

Hypothyroidism and its rapid correction alter cardiac remodeling

PloS one, 2014-10, Vol.9 (10), p.e109753

2014

Volltextzugriff (PDF)

Epidemiology of tuberculosis based on histopathological data and nucleic acid amplification techniques in Lebanon from January 2012 to December 2016

Clinical epidemiology and global health, 2021-07, Vol.11, p.100750, Article 100750

2021

Volltextzugriff (PDF)

More than meets the eye: intra-operative retrograde pyelography when more than one ureteral obstruction is suspected – A case report

Journal of pediatric surgery case reports, 2023-06, Vol.93, p.102645, Article 102645

2023

Volltextzugriff (PDF)

Epidemiology and Subtype Distribution of Lymphoid Neoplasms from a Single Institution in Lebanon between 2010 and 2014

Maġallat al-ṭibbiyat al-lubnāniyyat, 2018, Vol.66 (1), p.21-27

2018

Volltextzugriff (PDF)

Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma

Journal of Gastric Cancer, 2017, 17(2), , pp.180-185

2017

Volltextzugriff (PDF)

First live birth after uterus transplantation in the Middle East

Middle East Fertility Society journal, 2020-10, Vol.25 (1)

2020

Volltextzugriff (PDF)

Pathological effects and motor response threshold changes following radiofrequency application at various distances from the L-5 nerve root: an experimental study

Journal of neurosurgery. Spine, 2011-09, Vol.15 (3), p.285

2011

Volltextzugriff (PDF)

Idiopathic retroperitoneal fibrosis presenting as recurrent scrotal edema: Report of a case and review of the literature

Maġallat al-ṭibbiyat al-lubnāniyyat, 2014-01, Vol.62 (1), p.48-53

2014

Volltextzugriff (PDF)

Schistosomiasis manifesting as a colon polyp: a case report

Journal of medical case reports, 2014-10, Vol.8 (1), p.331-331, Article 331

2014

Volltextzugriff (PDF)

Epidermoid cyst of the spleen: case report

Maġallat al-ṭibbiyat al-lubnāniyyat, 2009-10, Vol.57 (4), p.268

2009

Volltextzugriff (PDF)

Prostate-specific membrane antigen (PSMA) expression in patients with metastatic triple negative breast cancer: Initial results of the PRISMA study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1025-1025

2023

Volltextzugriff (PDF)

Fish oil attenuates neurologic severity of antiphospholipid syndrome in a mice experimental model

Nutritional neuroscience, 2017-11, Vol.20 (10), p.563-570

2017

Volltextzugriff (PDF)

Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma

Journal of gastric cancer, 2017, Vol.17 (2), p.180-185

2017

Volltextzugriff (PDF)

Krüppel-like factor 4: A new potential biomarker of lung cancer

Molecular and clinical oncology, 2016-07, Vol.5 (1), p.35-40

2016

Volltextzugriff (PDF)

A phase I study of BOS172738 in patients with advanced solid tumors with RET gene alterations including non-small cell lung cancer and medullary thyroid cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS3162-TPS3162

2019

Volltextzugriff (PDF)

EMERALD: A randomized, open label, phase III trial to evaluate the efficacy and safety of elacestrant (RAD1901) versus investigator’s choice (IC) of endocrine therapy (ET) for ER+/HER2- advanced breast cancer (BC) following CDK4/6 inhibitor (CDK4/6i) therapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS1104-TPS1104

2019

Volltextzugriff (PDF)

Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1019-1019

2023

Volltextzugriff (PDF)

Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.547-547

2020

Volltextzugriff (PDF)

Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS1107-TPS1107

2021

Volltextzugriff (PDF)

A phase 1b/2 study of the BET inhibitor ZEN-3694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1023-1023

2022

Volltextzugriff (PDF)

A 5-year survey of biopsy proven kidney diseases in Lebanon: significant variation in prevalence of primary glomerular diseases by age, population structure and consanguinity

Nephrology, dialysis, transplantation, 2010-12, Vol.25 (12), p.3962-3969

2010

Volltextzugriff (PDF)

Results from a first-in-man, open label, safety and tolerability trial of CAN04 (nidanilimab), a fully humanized monoclonal antibody against the novel antitumor target, IL1RAP, in patients with solid tumor malignancies

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2504-2504

2019

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(62)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis

Hypothyroidism and its rapid correction alter cardiac remodeling

Epidemiology of tuberculosis based on histopathological data and nucleic acid amplification techniques in Lebanon from January 2012 to December 2016

More than meets the eye: intra-operative retrograde pyelography when more than one ureteral obstruction is suspected – A case report

Epidemiology and Subtype Distribution of Lymphoid Neoplasms from a Single Institution in Lebanon between 2010 and 2014

Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma

First live birth after uterus transplantation in the Middle East

Pathological effects and motor response threshold changes following radiofrequency application at various distances from the L-5 nerve root: an experimental study

Idiopathic retroperitoneal fibrosis presenting as recurrent scrotal edema: Report of a case and review of the literature

Schistosomiasis manifesting as a colon polyp: a case report

Epidermoid cyst of the spleen: case report

Prostate-specific membrane antigen (PSMA) expression in patients with metastatic triple negative breast cancer: Initial results of the PRISMA study

Fish oil attenuates neurologic severity of antiphospholipid syndrome in a mice experimental model

Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma

Krüppel-like factor 4: A new potential biomarker of lung cancer

A phase I study of BOS172738 in patients with advanced solid tumors with RET gene alterations including non-small cell lung cancer and medullary thyroid cancer

EMERALD: A randomized, open label, phase III trial to evaluate the efficacy and safety of elacestrant (RAD1901) versus investigator’s choice (IC) of endocrine therapy (ET) for ER+/HER2- advanced breast cancer (BC) following CDK4/6 inhibitor (CDK4/6i) therapy

Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative

Oral elacestrant vs standard-of-care in estrogen receptor-positive, HER2-negative (ER+/HER2-) advanced or metastatic breast cancer (mBC) without detectable ESR1 mutation (EMERALD): Subgroup analysis by prior duration of CDK4/6i plus endocrine therapy (ET)

Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery

Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2)

A phase 1b/2 study of the BET inhibitor ZEN-3694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations

Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), versus investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/metastatic breast cancer (mBC)

A 5-year survey of biopsy proven kidney diseases in Lebanon: significant variation in prevalence of primary glomerular diseases by age, population structure and consanguinity

Results from a first-in-man, open label, safety and tolerability trial of CAN04 (nidanilimab), a fully humanized monoclonal antibody against the novel antitumor target, IL1RAP, in patients with solid tumor malignancies

Suchergebnisse filtern